A multicenter, open-labeled, phase 2a study of AG-73305, a novel bi-specific Fc-fusion protein for the treatment of diabetic macular edema

AG-73305 - Allgenesis Biotherap

Tan Nguyen1; Sunil Patel1; Janet K. Cheetham3,1; David S. Boyer4; Artemis Wu1; Larry A. Wheeler2,1; Madhu Cherukury1

Apr 15, 2024